Literature DB >> 21569114

Psoriasis and hypertension: a case-control study.

S Armesto1, P Coto-Segura, C G Osuna, P M Camblor, J Santos-Juanes.   

Abstract

BACKGROUND: Several studies stated that patient with psoriasis carried an increased risk of psoriasis but some studies did not demonstrate this association.
OBJECTIVES: The aim of this study was to evaluate the prevalence of hypertension in psoriasis based on a sample of Spanish population.
METHODS: This was a hospital-based case-control study involving 661 psoriatic patients (cases) and 661 control matched by gender and age. Meta-analysis of the previous studies was made.
RESULTS: The prevalence of hypertension was significantly higher in psoriasis patients than controls (30.3%, 21.3%, respectively, P < 0.001). In a multivariate analysis, hypertension was associated with psoriasis after controlling for age, gender, diabetes, obesity and smoking (OR = 1.44, 95% confidence interval: 1.07-1.94).
CONCLUSION: The results of this study support the association between psoriasis and hypertension.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21569114     DOI: 10.1111/j.1468-3083.2011.04108.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies.

Authors:  Saumya Choudhary; Rachana Patel; Dibyabhaba Pradhan; Ravi Deval; Harpreet Singh; George Thomas; Arun Kumar Jain
Journal:  3 Biotech       Date:  2020-02-07       Impact factor: 2.406

2.  Hypertension, antihypertensive medication use, and risk of psoriasis.

Authors:  Shaowei Wu; Jiali Han; Wen-Qing Li; Abrar A Qureshi
Journal:  JAMA Dermatol       Date:  2014-09       Impact factor: 10.282

Review 3.  Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

Authors:  Stephen Chu-Sung Hu; Cheng-Che E Lan
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

4.  Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study.

Authors:  Ha-Na Kim; Kyungdo Han; Sang-Wook Song; Ji Hyun Lee
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

5.  Young patients with risk factors prevalent in the elderly - differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers.

Authors:  Mohammadhossein Hajiebrahimi; Marie Linder; David Hägg; Ina Anveden Berglind; Sean McElligott; Valgard Sverrir Valgardsson; Reginald Villacorta; Anders Sundström
Journal:  Clin Epidemiol       Date:  2018-06-19       Impact factor: 4.790

6.  Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice.

Authors:  Cristina Galache Osuna; Borja Gómez-Vila; Javier Aubán Pariente; Beatriz Vázquez Losada; Celia Gómez de Castro; Sheila Requena López; Álvaro de Dios Velázquez; Laura Palacios García; Lucía Ordoñez Fernández; Santiago Gómez Diez; Francisco Vázquez López; Jorge Santos-Juanes
Journal:  Medicina (Kaunas)       Date:  2020-10-30       Impact factor: 2.430

Review 7.  Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health.

Authors:  Meron Teklu; Philip M Parel; Nehal N Mehta
Journal:  Psoriasis (Auckl)       Date:  2021-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.